Staying the Course. Life Sciences and Materials Sciences. Feike Sijbesma Chairman Managing Board. December 3, 2009 Merrill Lynch Conference, London

Size: px
Start display at page:

Download "Staying the Course. Life Sciences and Materials Sciences. Feike Sijbesma Chairman Managing Board. December 3, 2009 Merrill Lynch Conference, London"

Transcription

1 Life Sciences and Materials Sciences Staying the Course Feike Sijbesma Chairman Managing Board December 3, 2009 Merrill Lynch Conference, London 0

2 Agenda Current business conditions DSM is Staying the Course 1

3 Highlights Q DSM delivers strong result improvement in Q3 Q3 operating profit from continuing operations EUR 139 million, more than double Q (EUR 58 million) Strong Life Sciences performance due to robust Nutrition business Materials Sciences continued strong recovery Cost savings and efficiency improvements on track to achieve EUR million on yearly basis by 2010 Cash flow from operating activities again very strong (Q3 EUR 517 million) Outlook for the rest of the year remains uncertain; Q4 operating profit currently expected to be lower than Q3 2009, but above Q

4 DSM is Staying the Course Continued commitment to customers, innovation and sustainability And: Focus on cash Execute cost savings program Capture market opportunities Speed up culture change Cash flow from operating activities Q1 '08 Q2 '08 Q3 '08 Q4 '08 Q1 '09 Q2 '09 Q3 '09 Priorities set to weather the storm 3

5 New market successes in the recession Sustainability driving opportunities in current market conditions 4

6 Strong financial position maintained Gearing of 18% at the end of Q3 No Commercial Paper outstanding and committed credit facilities are fully undrawn Strong balance sheet and financial flexibility Credit ratings unchanged Pension funds sufficiently funded (no additional cash contribution expected in 2009 and 2010) Debt Maturity Profile ( m) Bonds and Private Loans Dividend policy unchanged: Stable and preferably rising 5

7 Sustained high performance at Nutrition Profitability strengthened further Increased vitamin profitability Solid growth in enzymes Strong arachidonic acid sales Strategic focus Strengthen market leadership The only integrated full portfolio player Focus on cost leadership EBITDA Q1 07 Q3 09 Q1 '07 Q3 '07 Q1 '08 Q3 '08 Q1 '09 Q3 '09 Value creation by differentiation, segmentation and innovation 6

8 Pharma going through difficult times DSM Pharmaceutical Products Among leading global players Reduced demand in 2009 Improved pipeline (early stage) Successful tech transfer esp. in secondary manufacturing Cost restructuring in progress DSM Anti-Infectives Competitive environment Partnering strategy continued Profitable but at a low level Challenging business conditions remain, but improvement expected 7

9 Conditions improving in Materials Sciences 30% of business Still down 55% of business Improving 15% of business Resilient DEP: Building & Construction DR: Transport / Trucks Building & Construction DFI North American Fibers, Automotive DEP: Automotive, Electrical & electronics DYN: Commercial Marine, Sports High Performance Textiles DR: Consumer Related DFI: Textile / Tire Cord Asia Europe: Caprolactam, ACN DEP: Food packaging DYN: Life Protection, Medical DR: Optical Fiber Graphic Arts Demand in some markets still clearly below pre-recession levels 8

10 Outlook 2009 per cluster Nutrition results 2009 expected to be somewhat above 2008 Pharma results substantially lower than last year, but strong in Q Performance Materials results expected to be lower in Q than Q Polymer Intermediates 2009 results expected to be around break-even Base Chemicals and Materials clearly loss-making in 2009 Q4 '09 operating profit currently expected to be lower than Q3 '09 9

11 DSM priorities for 2010 Continued commitment to customers, innovation and sustainability Market demand Continuation of current priorities Focus on cash, cost savings and market opportunities Reduce capex and OWC Prepared for a potential recovery Fulfill additional demand Financial flexibility to finance growth Demand Time? Uncertainty about development of end-market demand remains 10

12 Agenda Current business conditions DSM is Staying the Course 11

13 Focus on Life Sciences and Materials Sciences Climate and Energy Health and Wellness Functionality and Performance Emerging Economies Life Sciences Materials Sciences Nutrition Pharma EBAs Performance Materials Polymer Intermediates Unique portfolio enabling crossover innovation 12

14 Progress with the portfolio shift Disposals and restructuring Disposal of urea licensing business and Energy business MBO of DSM Deretil side chain business Closure of Citric Acid site in Wuxi and clavulanic acid business Other disposals ongoing Acquisitions and partnerships Contracts with NCPC are suspended DSM s polycarbonate business swapped for Mitsubishi Chemical Corporation s polyamide business Targeted small acquisitions e.g. Biopract, Medivas LLC, venturing Target completion of disposals by the end of

15 Strategic focus on emerging economies Sales by Destination 2008 North America 18% 28% 5% C/E Europe 7% Latin America 8% China Presence in Emerging Economies % of sales 30% 25% 8% Emerging Asia Pacific Western Europe 48% Rest of World 6% (incl. Japan, Korea) 20% 15% Share of sales to emerging economies continues to increase 14

16 Continued innovation growth despite recession Full commitment to innovation Continued strong growth in 2009 High number of launches: 44 in first three quarters of 2009 External recognition: million 1.0bn Additional innovation sales 770m 600m 350m 170m outstanding corporate innovator Nutrition Performance Materials Pharma/Other All clusters Projected additional sales m, 1bn target in

17 Number 1. Dow Jones Sustainability World Index Leader 2009 / 2010 Social: People Sustainability embedded in our company More diverse workforce Responsible partner in society Environmental: Planet Improve eco-footprint throughout the value chain Leader in white biotechnology Triple Bottom Line Economic: Profit Sustainable value creation for our shareholders and customers CFROI > 8.5% Simultaneously creating value along three dimensions 16

18 Hidden Hunger a global challenge Definition: Enough calories to stay alive, but Not enough vitamins and minerals to be mentally and physically healthy Partnering Involvement Nutrition Improvement Program Recognition Business Over 2 billion people affected worldwide, claiming 10 million lives every year 17

19 Conclusions Strong improvement of results in Q3 2009, more than double Q Resilience in Nutrition; Materials Sciences continues strong recovery Successful cash generation and cost savings program continued Strong balance sheet and financial flexibility Continued focus on sustainability and culture change Commitment to customers and innovation to capture market opportunities DSM is Staying the Course 18

A short introduction to DSM (2017) The global science-based company active in health, nutrition and materials

A short introduction to DSM (2017) The global science-based company active in health, nutrition and materials A short introduction to DSM (2017) The global science-based company active in health, nutrition and materials Mission Our purpose is to create brighter lives for people today and generations to come We

More information

Press Information. From coal-mining to Life Sciences and Materials Sciences A history of successful transformation

Press Information. From coal-mining to Life Sciences and Materials Sciences A history of successful transformation Press Information DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com From coal-mining to Life Sciences and Materials Sciences DSM has a long

More information

4.3. Materials Sciences includes the Performance Materials and Polymer Intermediates clusters of DSM.

4.3. Materials Sciences includes the Performance Materials and Polymer Intermediates clusters of DSM. 4.1 4.2 4.3 Materials Sciences includes the Performance Materials and Polymer Intermediates clusters of DSM. The Performance Materials cluster comprises the business groups DSM Engineering Plastics, DSM

More information

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona Health Care Worldwide Crédit Suisse Global Credit Products Conference October 1, 2015 - Barcelona Safe Harbor Statement This presentation contains forward-looking statements that are subject to various

More information

Quarterly Results. Clariant Reports Strong Cash Flow Despite Continuing Weak Demand

Quarterly Results. Clariant Reports Strong Cash Flow Despite Continuing Weak Demand www.clariant.com Clariant International Ltd Rothausstrasse 61 4132 Muttenz 1 Switzerland Second Quarter 2009, Clariant Reports Strong Cash Flow Despite Continuing Weak Demand Sales in Q2 down 21% in local

More information

DSM in motion: Sustainability as business growth driver. Fernando Cisneros DSM Nutritional Products Kaiseraugst, Switzerland

DSM in motion: Sustainability as business growth driver. Fernando Cisneros DSM Nutritional Products Kaiseraugst, Switzerland DSM in motion: Sustainability as business growth driver Fernando Cisneros DSM Nutritional Products Kaiseraugst, Switzerland Business impact of the societal trends increasing Global Shifts Demographic shifts

More information

Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam

Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam Welcome and good morning. It is a pleasure to be here today to share our 2007 results and provide

More information

Enhancing Productivity. Innovative customer solutions to enhance productivity. Spectris plc Interim Results. 28 July 2016.

Enhancing Productivity. Innovative customer solutions to enhance productivity. Spectris plc Interim Results. 28 July 2016. Enhancing Productivity Innovative customer solutions to enhance productivity Spectris plc 2016 Interim Results 28 July 2016 Agenda Summary and Outlook Financial Performance Strategic Progress and Business

More information

Life Sciences and Material Sciences

Life Sciences and Material Sciences Life Sciences and Material Sciences Stephan B. Tanda Member Managing Board Royal DSM Volkert Claassen VP White Biotechnolgy Royal DSM Carnegie Bank, Denmark, 1 May 2009 0 Safe Harbor Statement This presentation

More information

2004 Full-Year Results Briefing

2004 Full-Year Results Briefing Venture Corporation Limited 2004 Full-Year Results Briefing 21 February 2005 FY04 Performance Review Group Revenue S$million 3,500 FY04 vs. FY03 : 1% 3,170 3,194 3,000 2,367 2,500 2,000 1,431 1,500 1,000

More information

Embracing Sustainability. Corporate Responsibility Relations February 2018

Embracing Sustainability. Corporate Responsibility Relations February 2018 Embracing Sustainability Corporate Responsibility Relations February 2018 1 Table of contents 1. Evonik global leader in specialty chemicals 2. Our sustainability strategy, commitments and targets 3. Sustainability

More information

Building the new Solvay: a value creative transformation

Building the new Solvay: a value creative transformation Building the new Solvay: a value creative transformation Jean-Pierre Clamadieu Chief Executive Officer April 24, 2012 AGENDA 1 Strong fundamentals 2 A well defined strategy 3 A transformation already underway

More information

Preliminary Results Announcement June 9 th 2009

Preliminary Results Announcement June 9 th 2009 1959-2009 Celebrating 50 years of scientific excellence and innovation Preliminary Results Announcement June 9 th 2009 Agenda Overview Financial Summary Operational Review & Outlook Jonathan Flint Kevin

More information

Third Quarter 2017 Financial Results. November 9, 2017

Third Quarter 2017 Financial Results. November 9, 2017 Third Quarter 2017 Financial Results November 9, 2017 Disclaimer This presentation contains forward-looking statements of Indorama Ventures Public Company Limited (the Company )1 that relate to future

More information

Avery Dennison Investor Presentation August 2014

Avery Dennison Investor Presentation August 2014 Avery Dennison Investor Presentation August 2014 Unless otherwise indicated, the discussion of the company s results is focused on its continuing operations, and comparisons are to the same period in the

More information

March Company Description

March Company Description March 2013 Company Description Jones Lang LaSalle Global real estate services Strategic, fully integrated services for real estate owners, occupiers and investors Productivity and cost solutions for corporate

More information

Life Sciences and Material Sciences

Life Sciences and Material Sciences Life Sciences and Material Sciences Stephan Tanda Member Managing Board Royal DSM Kempen & Co Conference, Brussels, 26 March 2009 Safe Harbor Statement This presentation may contain forward-looking statements

More information

Henkel Annual Results Press Conference

Henkel Annual Results Press Conference Henkel Annual Results Press Conference Kasper Rorsted Carsten Knobel Kathrin Menges Düsseldorf March 4, 2015 Disclaimer This information contains forward-looking statements which are based on current estimates

More information

Health Care Worldwide. Bank of America, 2007 Health Care Conference, May 30, 2007

Health Care Worldwide. Bank of America, 2007 Health Care Conference, May 30, 2007 Health Care Worldwide Bank of America, 2007 Health Care Conference, May 30, 2007 1 Fresenius This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future

More information

An introduction to Royal DSM. A purpose-led science-based company active in Nutrition, Health and Sustainable Living

An introduction to Royal DSM. A purpose-led science-based company active in Nutrition, Health and Sustainable Living An introduction to Royal DSM A purpose-led science-based company active in Nutrition, Health and Sustainable Living Contents DSM at a glance Strategy: Growth & Value - Purpose led, Performance driven Contact

More information

1.3. potential between Life Sciences and Materials Sciences internally referred to as the X-factor is high.

1.3. potential between Life Sciences and Materials Sciences internally referred to as the X-factor is high. 1.1 1.2 1.3 DSM s strategy over the last strategy period can be summarized in one slide. DSM s focus on Life Sciences (Nutrition and Pharma) and Materials Sciences (Performance Materials and Polymer Intermediates)

More information

Conference Call Q3/2016 Results

Conference Call Q3/2016 Results Conference Call Q3/206 Results Bad Homburg, 27 October 206 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains forward-looking

More information

Acquisition of Monsanto to Create a Global Leader in Agriculture

Acquisition of Monsanto to Create a Global Leader in Agriculture Acquisition of Monsanto to Create a Global Leader in Agriculture Innovation Powerhouse to Deliver Integrated Solutions for the Next Generation of Farming dbaccess German, Swiss & Austrian Conference June

More information

Solid activity levels Robust business development model

Solid activity levels Robust business development model 3 rd quarter Solid activity levels Robust business development model Paris, October 26, Pierre Dufour, Senior Executive Vice-President Jean-Pierre Duprieu, Executive Vice-President Fabienne Lecorvaisier,

More information

DSM Engineering Plastics Roeland Polet President DSM Engineering Plastics ROYAL DSM HEALTH NUTRITION MATERIALS

DSM Engineering Plastics Roeland Polet President DSM Engineering Plastics ROYAL DSM HEALTH NUTRITION MATERIALS DSM Engineering Plastics Roeland Polet President DSM Engineering Plastics ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect

More information

Enhancing Productivity Spectris plc Interim Results

Enhancing Productivity Spectris plc Interim Results Enhancing Productivity Spectris plc Interim Results 25 July 1 Agenda Highlights Financial Performance Business Update Summary and Outlook 2 Highlights Solid performance from Test & Measurement, In-line

More information

DSM Resins & Functional Materials Helen Mets President DSM Resins & Functional Materials ROYAL DSM HEALTH NUTRITION MATERIALS

DSM Resins & Functional Materials Helen Mets President DSM Resins & Functional Materials ROYAL DSM HEALTH NUTRITION MATERIALS DSM Resins & Functional Materials Helen Mets President DSM Resins & Functional Materials ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements

More information

Solid start into the year

Solid start into the year Deutsche Post DHL Group results Q 203 Solid start into the year Larry Rosen, CFO Bonn, 4 May 203 Q 203 Highlights (/2) Delivering solid results in still challenging macro-environment EBIT increase reflects

More information

Solvay, Enabling tomorrow

Solvay, Enabling tomorrow Solvay, Enabling tomorrow Fortuna beleggingsclub September 7, 2017 SAFE HARBOR This presentation may contain forward-looking information. Forwardlooking statements describe expectations, plans, strategies,

More information

Update of the 2020 Group Business Plan. August 3, 2018

Update of the 2020 Group Business Plan. August 3, 2018 Update of the 2020 Group Business Plan August 3, 2018 DISCLAIMER This presentation may contain forward looking statements based on current expectations and projects of the Group in relation to future events.

More information

Q Qualitative Business Update Mid-Term Guidance Until End 2018

Q Qualitative Business Update Mid-Term Guidance Until End 2018 Pharma&Biotech Corporate Q1 2015 Qualitative Business Update Mid-Term Guidance Until End 2018 Richard Ridinger CEO Richard Ridinger / Lonza Group Ltd, Basel / 28 April 2015 Lonza Overview Q1 2015 Qualitative

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

Annual General Meeting. Fresenius Medical Care AG & Co. KGaA

Annual General Meeting. Fresenius Medical Care AG & Co. KGaA Annual General Meeting Fresenius Medical Care AG & Co. KGaA Speech to the Shareholders by Dr. Ben J. Lipps May 10, 2012 Spoken word takes precedence 1 Slide 1: Welcome Welcome to our Annual General Meeting

More information

Full year results Amsterdam, 5 February 2015

Full year results Amsterdam, 5 February 2015 Full year results 2014 Amsterdam, 5 February 2015 Disclaimer The information contained herein shall not constitute or form any part of any offer or invitation to subscribe for, underwrite or otherwise

More information

Investor Presentation

Investor Presentation Investor Presentation Michael Willome, Group CEO Baader Helvea Swiss Equities Conference Content Group overview & priorities Page 3 Segment performance, sales trend & outlook Page 10 Appendix: Leadership

More information

The 31st Annual Gabelli Automotive Aftermarket Symposium. Lear s Asian Strategy

The 31st Annual Gabelli Automotive Aftermarket Symposium. Lear s Asian Strategy The 31st Annual Gabelli Automotive Aftermarket Symposium Lear s Asian Strategy October 31, 2007 Agenda Company Overview Bob Rossiter, Chairman, CEO and President Lear s Asian Strategy Lou Salvatore, Senior

More information

Mike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference.

Mike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference. Mike Roman Chief Operating Officer & Executive Vice President Bank of America Merrill Lynch Global Industrials Conference March 22, 2018 1 Building strength-on-strength and positioned for growth 2017 Executing

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Roadshow Benelux June 29/30, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q3 2018 1 Forward-Looking Statements Statements in this presentation that express a belief, expectation or intention,

More information

THOMSON REUTERS THIRD QUARTER 2008 NOVEMBER 12, 2008

THOMSON REUTERS THIRD QUARTER 2008 NOVEMBER 12, 2008 THOMSON REUTERS THIRD QUARTER 2008 NOVEMBER 12, 2008 Agenda Welcome / Introduction Frank Golden Q3 2008 Headlines Market Environment Looking Ahead Tom Glocer Financial Review Bob Daleo Q & A 2 Special

More information

Biobased ECO+ Solutions from DSM

Biobased ECO+ Solutions from DSM Biobased ECO+ Solutions from DSM Applications in Green Plastics: Emile Homsi, Ph.D., LLM VP R&T DSMEP May 10-2013 DSM Organization chart DSM Managing Board DSM Innovation Center Corporate Staff Shared

More information

4.1. This presentation outlines how DSM s corporate strategy DSM in motion: driving focused growth will be driven through our pharma cluster.

4.1. This presentation outlines how DSM s corporate strategy DSM in motion: driving focused growth will be driven through our pharma cluster. 4.1 This presentation outlines how DSM s corporate strategy DSM in motion: driving focused growth will be driven through our pharma cluster. DSM has made considerable progress in addressing the challenges

More information

2012 Full Year Results. Media presentation

2012 Full Year Results. Media presentation 2012 Full Year Results Media presentation Basel: February 6, 2013 2012 Syngenta highlights Strong sales momentum: +10% CER - developed market growth 8%; emerging 11% Commercial integration complete Double-digit

More information

CONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY

CONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY CONFERENCE CALL 205 RESULTS Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements that

More information

Chargeurs: a world of niche market leaders

Chargeurs: a world of niche market leaders Chargeurs: a world of niche market leaders The transforming acquisition of US & Asia based Precision Custom Coatings Interlining (PCC) by Chargeurs Fashion Technologies June 28, 2018 AGENDA 1. Since 2015,

More information

Company Overview. November 2017

Company Overview. November 2017 Company Overview November 2017 DCC Overview DCC is a leading international sales, marketing and support services group operating across four divisions Profit by division * Profit by geography * 12% 5%

More information

Jefferies 2018 Global Healthcare Conference. June 7, 2018

Jefferies 2018 Global Healthcare Conference. June 7, 2018 Jefferies 2018 Global Healthcare Conference June 7, 2018 Forward-Looking Statements Statements in this presentation regarding the future financial and operating results, outlook, growth, prospects, business

More information

2014 First Quarter Business Review

2014 First Quarter Business Review 2014 First Quarter Business Review (unaudited) April 24, 2014 2014 First Quarter Business Review Forward Looking Statements This presentation contains forward-looking information about 3M's financial results

More information

BASF Monomers Division Excellence in Commodities

BASF Monomers Division Excellence in Commodities Stefano Pigozzi President Monomers Division BASF Monomers Division Excellence in Commodities Investor Day Chemicals segment May 22, 2014 BASF Investor Day Chemicals segment Monomers, May 22, 2014 1 Cautionary

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q1 2018 1 Forward-Looking Statements Statements in presentation that express a belief, expectation or intention,

More information

Results for the year ended 31 March Richard Longdon, Chief Executive James Kidd, Chief Financial Officer

Results for the year ended 31 March Richard Longdon, Chief Executive James Kidd, Chief Financial Officer Results for the year ended 31 March 2012 Richard Longdon, Chief Executive James Kidd, Chief Financial Officer Safe Harbor Statement During (and in this) presentation we make forward-looking statements.

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q2 2018 1 Forward-Looking Statements Statements in presentation that express a belief, expectation or intention,

More information

STRATEGY FOCUS FOCUS FOCUS

STRATEGY FOCUS FOCUS FOCUS STRATEGY FOCUS FOCUS FOCUS Per H. Utnegaard, Axel Salzmann, Dr. Jochen Keysberg, October 15, 2015 CEO Assessment We can build on our strengths High-quality services provider and partner to our customers

More information

Annual General Meeting of Shareholders

Annual General Meeting of Shareholders Annual General Meeting of Shareholders Nancy McKinstry CEO and Chairman of the Executive Board Forward-looking Statements This presentation contains forward-looking statements. These statements may be

More information

Welcome to the Annual General Meeting 2014 of the Nemetschek AG. Munich, May 20, 2014, Conference Center Munich at the Hanns-Seidel-Stiftung

Welcome to the Annual General Meeting 2014 of the Nemetschek AG. Munich, May 20, 2014, Conference Center Munich at the Hanns-Seidel-Stiftung Welcome to the Annual General Meeting 2014 of the Nemetschek AG Munich, May 20, 2014, Conference Center Munich at the Hanns-Seidel-Stiftung Annual General Meeting 2014 Kurt Dobitsch, Chairman of the Supervisory

More information

Lighting Strategy. Key takeaways. We continue to grow at mid single digit and are taking decisive actions to address margin issues

Lighting Strategy. Key takeaways. We continue to grow at mid single digit and are taking decisive actions to address margin issues Lighting Strategy Frans van Houten a.i. CEO Philips Lighting 2 3 Key takeaways 24 1 Key takeaways 25 We have undertaken actions to address issues with our performance Results impacted by Slower market

More information

Jukka Moisio, CEO. SEB Nordic Seminar 2017, Copenhagen January 10, 2017

Jukka Moisio, CEO. SEB Nordic Seminar 2017, Copenhagen January 10, 2017 Jukka Moisio, CEO SEB Nordic Seminar 2017, Copenhagen January 10, 2017 We re the global specialist in packaging for food and drink Net sales 2.8bn Comparable growth 4% EBIT margin 9% ROI 15% Our ambition

More information

6 MARCH 2017 BUSINESS UPDATE

6 MARCH 2017 BUSINESS UPDATE 6 MARCH 2017 BUSINESS UPDATE 1 Today s presenters Peter Page Chief Executive Rutger Helbing Group Finance Director Michael Lauesgaard Group Business Development Director 2 Devro the outlook Global demand

More information

Novozymes Conference Call 1H August 11, 2017

Novozymes Conference Call 1H August 11, 2017 Novozymes Conference Call 1H 2017 August 11, 2017 2 1H 2017 Highlights Good first half and momentum in the business Organic sales growth +3% (Q2: 2%) Large segments growing organically: Household Care

More information

Enea Full Year Results Åsa Landén Ericsson, CEO February 6, 2009

Enea Full Year Results Åsa Landén Ericsson, CEO February 6, 2009 Enea Full Year Results 2008 Åsa Landén Ericsson, CEO February 6, 2009 Agenda Corporate Overview Highlights and Financials 2008 Market Outlook, Opportunities and Growth Factors Leader in Communications

More information

Mitsubishi Corporation. Midterm Corporate Strategy 2021

Mitsubishi Corporation. Midterm Corporate Strategy 2021 Mitsubishi Corporation Midterm Corporate Strategy 2021 Achieving Through Business Management Model November 2, 2018 Mitsubishi Corporation Takehiko Kakiuchi Copyright 2018 Mitsubishi Corporation Outline

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Roadshow Copenhagen October 6, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

ThyssenKrupp Industrial Solutions

ThyssenKrupp Industrial Solutions ThyssenKrupp Hans Christoph Atzpodien Wir entwickeln die Zukunft für Sie. Engineering Powerhouse Within ThyssenKrupp Business Units Engineering (E) (Sales: 5,641 m; Employees: 18,841) Procurement (P) Similar

More information

SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION SEC FORM 17-C CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATIONS CODE (SRC) AND SRC RULE 17(a)-1(b)(3) THEREUNDER 1. January 7, 2014 Date of Report (Date of

More information

PRESS RELEASE FIRST QUARTER 2016 FIRST QUARTER SALES Paris, June 1, 2016

PRESS RELEASE FIRST QUARTER 2016 FIRST QUARTER SALES Paris, June 1, 2016 FIRST QUARTER SALES 2016 FIRST QUARTER 2016 Q1 2016 sales down 2.8% at constant 1 scope and exchange rates Decline in the SME Solutions division's sales: down 4.0%, at constant exchange rates Continued

More information

SIKA MADE BINDING OFFER TO ACQUIRE PAREX MEDIA AND ANALYST PRESENTATION JANUARY 8, 2019

SIKA MADE BINDING OFFER TO ACQUIRE PAREX MEDIA AND ANALYST PRESENTATION JANUARY 8, 2019 SIKA MADE BINDING OFFER TO ACQUIRE PAREX MEDIA AND ANALYST PRESENTATION JANUARY 8, 2019 AGENDA TRANSACTION HIGHLIGHTS PAREX A LEADING MORTAR MANUFACTURER TRANSACTION RATIONALE FINANCIAL CONSIDERATIONS

More information

Debt Investors Call Third-Quarter Walldorf, Germany Thursday, November

Debt Investors Call Third-Quarter Walldorf, Germany Thursday, November Debt Investors Call Third-Quarter 2015 Walldorf, Germany Thursday, November 5 2015 Safe Harbor Statement Any statements contained in this document that are not historical facts are forward-looking statements

More information

SKF Capital Markets Day Christian Johansson, Senior Vice President & CFO

SKF Capital Markets Day Christian Johansson, Senior Vice President & CFO SKF Capital Markets Day 2018 Christian Johansson, Senior Vice President & CFO SKF in business for 111 years, fit and ready for the future! Fast and customer focused Net debt / equity: 60% Target:

More information

DSM Capital Markets Day 2018

DSM Capital Markets Day 2018 DSM Capital Markets Day 2018 Growth & Value Purpose led, Performance driven. Feike Sijbesma CEO ROYAL DSM CAPITAL MARKETS DAY LONDON (UK) - 20 JUNE 2018 Safe harbor statement This presentation may contain

More information

Praxair, Inc. Kelcey E. Hoyt Director, Investor Relations. Wells Fargo Industrial & Construction Conference May 08, 2014

Praxair, Inc. Kelcey E. Hoyt Director, Investor Relations. Wells Fargo Industrial & Construction Conference May 08, 2014 Praxair, Inc. Kelcey E. Hoyt Director, Investor Relations Wells Fargo Industrial & Construction Conference May 08, 2014 Forward Looking Statement This document contains forward-looking statements within

More information

PerkinElmer, Inc. Andy Wilson, CFO May 13, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH. Bank of America Merrill Lynch Global Healthcare Conference

PerkinElmer, Inc. Andy Wilson, CFO May 13, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH. Bank of America Merrill Lynch Global Healthcare Conference PerkinElmer, Inc Bank of America Merrill Lynch Global Healthcare Conference Andy Wilson, CFO May 13, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer FACTORS AFFECTING FUTURE PERFORMANCE & NON-GAAP

More information

ISPE: Pharma Industry Outlook

ISPE: Pharma Industry Outlook ISPE: Pharma Industry Outlook ANDREW D. SKIBO Head of Global Biologics Operations & Global Engineering MedImmune/AstraZeneca Chairman, ISPE Board of Directors October 7, 2015 Linking Past ISPE Drivers

More information

Annual General Meeting. Fresenius Medical Care AG & Co. KGaA

Annual General Meeting. Fresenius Medical Care AG & Co. KGaA Annual General Meeting Fresenius Medical Care AG & Co. KGaA Speech to the Shareholders by Dr. Ben J. Lipps May 11, 2010 Spoken word takes precedence Fresenius Medical Care AG & Co. KGaA - 1 - Chart 1:

More information

2015 Interim Results. 12 August 2015

2015 Interim Results. 12 August 2015 2015 Interim Results 12 August 2015 Ashley Almanza Group CEO Legal Disclaimer Certain statements in this document are forward-looking statements. These forward-looking statements speak only as at the date

More information

Scaling private finance to achieve Paris climate goals

Scaling private finance to achieve Paris climate goals Scaling private finance to achieve Paris climate goals 24 January 2018 Barbara Buchner, Climate Policy Initiative Tom Kerr, International Finance Corporation Padraig Oliver, Climate Policy Initiative 1

More information

Rockwell Automation Company Overview August Copyright 2016 Rockwell Automation, Inc. All Rights Reserved.

Rockwell Automation Company Overview August Copyright 2016 Rockwell Automation, Inc. All Rights Reserved. Rockwell Automation Company Overview August 2016 Rev 5058-CO900E PUBLIC INFORMATION 2 Safe Harbor Statement This presentation includes statements related to the expected future results of the company and

More information

Deutsche Bank Conference. 15 June 2011, Paris

Deutsche Bank Conference. 15 June 2011, Paris Deutsche Bank Conference 15 June 2011, Paris Agenda Tate & Lyle Strategy and Operating Model Business Transformation Focus, Fix, Grow Key Results and Outlook 2 Clear strategy and simple operating model

More information

THE MMC ADVANTAGE: DELIVERING VALUE FOR THE ENERGY SECTOR. Strategic Solutions Group

THE MMC ADVANTAGE: DELIVERING VALUE FOR THE ENERGY SECTOR. Strategic Solutions Group THE MMC ADVANTAGE: DELIVERING VALUE FOR THE ENERGY SECTOR Strategic Solutions Group delivers advice and solutions that help clients protect and enhance shareholder value. We provide the advantage of four

More information

Our passion is to deliver sustainable value to our customers 2008 First Half Results 23 July 2008

Our passion is to deliver sustainable value to our customers 2008 First Half Results 23 July 2008 Our passion is to deliver sustainable value to our customers 2008 First Half Results 23 July 2008 Stefan Borgas Chief Executive Officer Disclaimer Certain matters discussed in this presentation may constitute

More information

For personal use only

For personal use only GALE Pacific Investor Presentation Results to 30 June 2015 September 2015 Who we are GALE Pacific manufactures and markets branded screening, shading and home improvement products. We are a world leader

More information

Managing Sustainable Breakthrough Innovation

Managing Sustainable Breakthrough Innovation Managing Sustainable Breakthrough Innovation Herman Wories VP Global Business Incubator DSM Innovation Center Barcelona 27 th February 2014 DSM Biomedical materials improve over 4.4 million people s lives,

More information

Results Meeting for 1H of the Fiscal Year Ending March 2018

Results Meeting for 1H of the Fiscal Year Ending March 2018 Results Meeting for 1H of the Fiscal Year Ending March 2018 NIPPON EXPRESS CO., LTD. 1. Business 2. Changes due to the External Environment 3. Performance Outlook of the Fiscal Year Ending March 2018 4.

More information

KUKA Aktiengesellschaft

KUKA Aktiengesellschaft KUKA Aktiengesellschaft Company Presentation 2018 Page: 1 Agenda 1. KUKA Group at a glance 2. Divisions, Strategy and Targets 3. Technology and Innovation 4. Shareholder Structure, Financials and Markets

More information

ABB LTD, ZURICH, SWITZERLAND, APRIL 19, 2018 Profitable growth. Q results. Ulrich Spiesshofer, CEO; Timo Ihamuotila, CFO

ABB LTD, ZURICH, SWITZERLAND, APRIL 19, 2018 Profitable growth. Q results. Ulrich Spiesshofer, CEO; Timo Ihamuotila, CFO ABB LTD, ZURICH, SWITZERLAND, APRIL 9, 208 Profitable growth Q 208 results Ulrich Spiesshofer, CEO; Timo Ihamuotila, CFO Important notices This presentation includes forward-looking information and statements

More information

Himanshu Raja CFO May 2014

Himanshu Raja CFO May 2014 Himanshu Raja CFO May 2014 Legal Disclaimer Certain statements in this document are forward-looking statements. These forward-looking statements speak only as at the date of this document. These statements

More information

Interim results Analysts' meeting. Thursday 23 August Agenda

Interim results Analysts' meeting. Thursday 23 August Agenda Interim results 2012 Analysts' meeting Thursday 23 August 2012 Agenda 1. Kendrion at a glance 2. Highlights for the first six months of 2012 3. Key figures and financial objectives 4. Review of the business

More information

Annual Shareholders' Meeting of Siemens AG. Report by President and CEO Dr. Klaus Kleinfeld Munich, January 25, 2007

Annual Shareholders' Meeting of Siemens AG. Report by President and CEO Dr. Klaus Kleinfeld Munich, January 25, 2007 Annual Shareholders' Meeting of Siemens AG Report by President and CEO Dr. Klaus Kleinfeld Munich, January 25, 2007 Robust growth in new orders and sales in millions of euros U.S. GAAP FY 2006 (FY 05 06)

More information

Profitable growth and net income result for Thiel Logistik

Profitable growth and net income result for Thiel Logistik Profitable growth and net income result for Thiel Logistik Net income of 1.0 million euros Operating income of 25 million euros - EBIT (US GAAP) 31.8 million euros Sales up 4 percent to 1.73 billion euros

More information

Dedicated to building a model of sustainable chemistry. Jean-Pierre Clamadieu, Chairman of the Executive Committee & CEO

Dedicated to building a model of sustainable chemistry. Jean-Pierre Clamadieu, Chairman of the Executive Committee & CEO Dedicated to building a model of sustainable chemistry Jean-Pierre Clamadieu, Chairman of the Executive Committee & CEO Multi-speed global economy 1.7% 1.6% 6.1% 6.9% NORTH AMERICA A Chemical Renaissance

More information

Company Overview Presentation

Company Overview Presentation Company Overview Presentation March 2013 Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any shares or other securities of

More information

Delivering Innovative Solutions for our Customers. Spectris plc Half Year Results. 24 July Spectris plc

Delivering Innovative Solutions for our Customers. Spectris plc Half Year Results. 24 July Spectris plc Delivering Innovative Solutions for our Customers Spectris plc 2018 Half Year Results 24 July 2018 Agenda 2018 Highlights Financial Performance Business Update and Strategic Progress Summary and Outlook

More information

Nokia Siemens Networks Integration & restructuring update. Eric A. Simonsen Chief Financial Officer

Nokia Siemens Networks Integration & restructuring update. Eric A. Simonsen Chief Financial Officer Nokia Siemens Networks Integration & restructuring update Eric A. Simonsen Chief Financial Officer 1 Nokia Siemens Networks Capital Markets Day 2007 Key quarterly figures in 2007 Geographic distribution

More information

Intelligent energy and data solutions for tomorrow's world. Investor Presentation Q1 2018

Intelligent energy and data solutions for tomorrow's world. Investor Presentation Q1 2018 Intelligent energy and data solutions for tomorrow's world Investor Presentation Q1 2018 A global leader in wiring systems and cable technology LEONI at a glance Industrial Solutions Business mix (in %

More information

BASF signs agreement to acquire significant parts of Bayer s seed and non-selective herbicide businesses. October 13, 2017

BASF signs agreement to acquire significant parts of Bayer s seed and non-selective herbicide businesses. October 13, 2017 BASF signs agreement to acquire significant parts of Bayer s seed and non-selective herbicide businesses October 13, 2017 Cautionary note regarding forward-looking statements This presentation contains

More information

Q2 Interim Report 2009

Q2 Interim Report 2009 Q2 Interim Report 2009 July 24, 2009 Slide 1 Slide 2 Q2 in Brief EUR million II/09 II/08 I-II/09 I-II/08 2008 Sales 67.7 74.2 132.9 139.4 243.0 EBITDA 11.5 15.4 23.1 27.6 37.5 EBITDA,excl. non-rec.items

More information

QUARTER MARKED BY A TEMPORARY UNDER- PERFORMANCE IN ENTERPRISE DIGITAL SOLUTIONS

QUARTER MARKED BY A TEMPORARY UNDER- PERFORMANCE IN ENTERPRISE DIGITAL SOLUTIONS 2017 THIRD-QUARTER SALES QUARTER MARKED BY A TEMPORARY UNDER- PERFORMANCE IN ENTERPRISE DIGITAL SOLUTIONS Q3 2017 sales down -2.5% on an organic basis 1 : o Enterprise Digital Solutions: stable performance

More information

Dear shareholders, Víctor Grífols President and CEO of Grifols

Dear shareholders, Víctor Grífols President and CEO of Grifols ANNUAL 2012 REPORT Dear shareholders, Grifols ushered in a new era in 2012, one that has seen the company become the world s third-largest producer of plasma-derived medicines following the acquisition

More information

Acquisition of UGS. Creating the world s first supplier of software and hardware across the complete product & production life cycle.

Acquisition of UGS. Creating the world s first supplier of software and hardware across the complete product & production life cycle. Acquisition of UGS Creating the world s first supplier of software and hardware across the complete product & production life cycle January 25, 2007 Helmut Gierse Disclaimer This document contains forward-looking

More information

Investor presentation: July October 2018 Responsible growth. Shared success.

Investor presentation: July October 2018 Responsible growth. Shared success. Investor presentation: July October 2018 Responsible growth. Shared success. Givaudan products drive millions of consumer decisions every day! F&F: the key driver of consumer repurchase decisions Critical

More information

Gamesa s net profit rose by 45% to reach 320 million

Gamesa s net profit rose by 45% to reach 320 million Gamesa s net profit rose by 45% to reach 320 million February, 26, 2009 EBITDA grew by 40% to reach 495 million while sales increased by 27% to reach 3.551 billion International markets contributed to

More information